Table 1 Patient demographics and clinical characteristics (n = 48)
From: Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma
Characteristic | N (range or %) |
|---|---|
Median (range) of age at diagnosis (years) | 58.0 (35–85) |
Median (range) between completion of initial treatment and PET/CT (months) | 6 (3–9) |
Mean ± SD between completion of initial treatment and PET/CT (months) | 5.5 ± 1.9 |
Median follow-up timea (months) | 47.3 (4.56–119.8) |
Death events | 22 (45.8 %) |
Median baseline CA-125 (U/mL) | 459 (14–8409) |
Median CA-125 at follow-up (U/mL) | 23.5 (2–626) |
FIGO stage | |
I and II | 4 (8.33 %) |
III and IV | 43 (89.58 %) |
Unknown | 1 (2.08 %) |
Histologic type | |
Serous | 35 (72.92 %) |
Not serous | 12 (25.00 %) |
Unknown | 1 (2.08 %) |
Tumor grade | |
High | 40 (83.33 %) |
Low | 2 (4.17 %) |
Unknown | 6 (12.50 %) |
Residual disease | |
Optimal debulking | 32 (66.67 %) |
Suboptimal debulking | 3 (6.25 %) |
Unknown | 13 (27.08 %) |
Initial treatment | |
Surgery | 48 (100 %) |
Adjuvant chemotherapy | 42 (87.5 %) |
Radiation therapy | 0 (0 %) |